Borer Denton & Associates’s Eli Lilly LLY Stock Holding History

Borer Denton & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Sell	2,602 -50	-2%	-$51.1K	1.02%	27
2026 Q1	$2.44M	Hold	2,652	–	–	0.87%	28
2025 Q4	$2.85M	Hold	2,652	–	–	0.96%	27
2025 Q3	$2.02M	Sell	2,652 -6	-0.2%	-$4.46K	0.67%	31
2025 Q2	$2.07M	Hold	2,658	–	–	0.72%	31
2025 Q1	$2.19M	Buy	2,658 +183	+7%	+$152K	0.78%	31
2024 Q4	$1.91M	Hold	2,475	–	–	0.66%	31
2024 Q3	$2.19M	Hold	2,475	–	–	0.75%	30
2024 Q2	$2.24M	Hold	2,475	–	–	0.81%	29
2024 Q1	$1.93M	Hold	2,475	–	–	0.68%	32
2023 Q4	$1.44M	Hold	2,475	–	–	0.55%	33
2023 Q3	$1.33M	Hold	2,475	–	–	0.55%	33
2023 Q2	$1.16M	Hold	2,475	–	–	0.46%	35
2023 Q1	$850K	Buy	2,475 +110	+5%	+$37.1K	0.35%	38
2022 Q4	$865K	Buy	2,365 +800	+51%	+$284K	0.38%	37
2022 Q3	$506K	Sell	1,565 -172	-10%	-$54.5K	0.25%	43
2022 Q2	$563K	Hold	1,737	–	–	0.27%	42
2022 Q1	$497K	Buy	+1,737	New	+$447K	0.21%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Borer Denton & Associates's LLY Position: Q2 2026 in Review

Borer Denton & Associates reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $51.1K and leaving 2,602 shares worth $3.12M. The position accounts for 1.02% of the portfolio, ranked #27.

Borer Denton & Associates first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Borer Denton & Associates held 2,602 shares of Eli Lilly worth $3.12M as of Q2 2026.
Borer Denton & Associates sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
Eli Lilly made up 1.02% of Borer Denton & Associates's portfolio in Q2 2026, its #27 holding.
Borer Denton & Associates first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Borer Denton & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.